Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 10, 2016 7:19 AM ET


Company Overview of Idera Pharmaceuticals, Inc.

Executive Profile

Vincent J. Milano

Chief Executive Officer, President and Director, Idera Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Vincent J. Milano, also known as Vinnie has been the Chief Executive Officer and President at Idera Pharmaceuticals, Inc. since December 1, 2014. Mr. Milano served as the Chief Executive Officer and President of ViroPharma Inc. from March 31, 2008 to January 24, 2014. He served as the Chief Operating Officer of ViroPharma Inc., from January 2006 to March 2008, Vice President from November 1997 to March 2008, Chief Financial Officer from November 1997 to October 2008, ...

Corporate Headquarters

167 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-679-5500
Fax: 617-679-5592

Board Members Memberships

Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Independent Director, Chairman of Compensation Committee and Member of Audit Committee
Member of The Board of Directors
Chief Executive Officer, President and Director
Director, Chairman of Audit Committee and Chairman of Compensation Committee


Rider University

Other Affiliations

Annual Compensation

Total Annual Compensation$50,000

Stocks Options

All Other Compensation$2,138
Unexercisable Options$2,000,000
Unexercisable Options Value$2,580,000
Total Value of Options$2,580,000
Total Number of Options$2,000,000

Total Compensation

Total Annual Cash Compensation$52,138
Total Short Term Compensation$50,000
Other Long Term Compensation$2,138
Total Calculated Compensation$4,029,538

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Idera Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at